Who is sponsoring NCT04187729?

NCT04187729 is sponsored by Intermountain Health Care, Inc..

What condition does NCT04187729 study?

NCT04187729 studies Any Disease Condition and Reportedly-healthy Subjects.

Is NCT04187729 still recruiting?

NCT04187729 is currently recruiting now. Last updated 20 April 2022.

Last reviewed 2022-04-20 · How we verify

NCT04187729: PRECISE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Precision Genomics Medicine Biobank

Recruiting now Last updated 20 April 2022

What this trial tests

trial in Any Disease Condition and Reportedly-healthy Subjects in 100,000 participants. Currently enrolling.

Timeline

24 October 2017

Primary endpoint
24 October 2067

24 October 2077

Quick facts

Lead sponsor	Intermountain Health Care, Inc.
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100,000
Start date	24 October 2017
Primary completion	24 October 2067
Estimated completion	24 October 2077
Sites	1 location across United States

Conditions studied

Any Disease Condition and Reportedly-healthy Subjects — all drugs for Any Disease Condition and Reportedly-healthy Subjects →

Sponsor

Intermountain Health Care, Inc. — full company profile →

Who can join

18 and older, any sex, with Any Disease Condition and Reportedly-healthy Subjects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Intermountain Health Care, Inc. trials

Trials by the same sponsor.

NCT07334795 — Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics · active not recruiting
NCT07348289 — PIVO Use for Blood Cultures in the Emergency Department · recruiting
NCT06865781 — Vital Signs Reduction Study · NA · active not recruiting
NCT05936021 — Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease U · NA · unknown
NCT05141396 — Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04187729 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Intermountain Health Care, Inc.
Last refreshed: 20 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04187729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing